{"text": "thinking of bmy over last 15 mo sold otezla for a great price tyk2 data might not have to pay out the cvr bought myok for a decent ish price borrowed money at insanely low protected revlimid through start of 26 luspatercept ozanimod launched not bad all in all"}
{"text": "bmy bristol myers squibb showcases research advancing outcomes addressing hard to treat blood cancers and diseases across small molecule biologic and cell therapies at ash 2020 biospace jobs"}
{"text": "just went through ronny gal bmy initiation has tyk2 psoriasis market share reaching 15 by 2030 otezla hardly efficacious does 18 today you do the math way too low"}
{"text": "bmy bearish engulfing daily appearances since 2010 112 close 5 days later avg 0 18 sd 1 70 worst 6 22 best 4 17 10 days later avg 0 16 sd 2 53 worst 7 53 best 6 39 30 days later avg 0 22 sd 4 58 worst 14 65 best 8 81"}
{"text": "bmy bristol myers squibb bristol myers squibb to participate in wolfe researchs 2nd annual virtual healt from our stock news alerts app"}
{"text": "15 42 drops bmy 4 5 pshg 3 5"}
